Clinical Trials

Only ~16% of supplements are clinically tested. CONKA® stands apart — clinically validated in gold-standard, double-blind, placebo-controlled trials, with its key bioactive formulations supported by extensive independent research.

CONKA Research – Randomised Controlled Trial

A four-week, double-blind, placebo-controlled trial tested the CONKA formula in 29 professional male contact sport athletes. Participants were split into a CONKA group (n = 18) and a placebo group (n = 11), with cognitive performance measured using the Integrated Cognitive Assessment (ICA) and a digital Sports Concussion Assessment Test (SCAT 6). Real-world factors like match minutes, head impacts, sleep, and recovery were also tracked.

Key Findings:

• CONKA users improved cognitive performance by +14.9%, while the placebo group slightly declined (-0.7%).
  
• Gains were seen across memory, attention, and processing speed, all statistically significant.
  
• The formula supports cognitive function, well-being, and post-competition recovery.
  

Takeaway:

CONKA is a safe, natural, evidence-backed solution that enhances brain performance in environments known to disrupt performance.

86% Reduction In Brain Fog

Blast mTBI Recovery Boosted by NAC

In a combat study with 81 service members, N-acetyl cysteine (NAC) significantly improved recovery from blast-induced mild traumatic brain injury. When given within 24 hours, 86% of participants fully recovered their cognitive and physical symptoms—compared to just 42% with placebo.

Safe, fast-acting, and effective, NAC is the first proven short-term intervention for blast-related mTBI.

Learn more

Reduces Anxiety

In a double-blind, placebo-controlled study with 13 healthy volunteers, a single dose of Ashwagandha improved working memory, sustained attention, and executive function over 6 hours. Participants also experienced a reduction in anxiety and mental fatigue, helping maintain focus and reaction times.

Read the study

CONKA Research – Open-Label Study

A four-week trial assessed Conka-1 in 44 professional contact sport athletes (28 male, 9 female rugby; 7 male football). Cognitive performance was tracked using the ICA, measuring speed, accuracy, and overall cognitive index, while wellness and recovery metrics ensured real-world relevance.

Key Findings:

• Speed: +22.1% for men, +33.5% for women (P < 0.01)
  
  
• Accuracy: +10.8% for men, +13.4% for women (P = 0.42)
  
  
• Overall cognitive index: +16.5% for men, +23.4% for women (P < 0.05)
  
  
• Improvements were consistent across genders, with statistically significant gains for both men and women.
  

Takeaway:

Conka-1 is a safe, WADA-compliant, food-based strategy that boosts mental processing speed, attention, and cognitive resilience, helping athletes maintain brain health under high-contact conditions.